Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer | BMC Medical Genetics | Full Text

Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer | BMC Medical Genetics | Full Text

Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer

This study aimed to explore the diagnostic value of serum miR-101-3p combined with pepsinogen (PG) on early diagnosis of gastric cancer (GC).

Authors:Weiwei Zeng, Shuxiang Zhang, Lei Yang, Wenchao Wei, Jie Gao, Ni Guo and Fengting Wu

Citation:BMC Medical Genetics 2020 21:28

Content type:Research article

Published on: 10 February 2020

• ViewFull Text
 
• ViewPDF